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Abstract— The paper presents experimental data on the 
influence of the product of the activity of the honey bee 
Apis mellifera Caucasica on the life span of experimental 
animals irradiated with small doses of gamma radiation. 
The aim of the studies was to study the radioprotective 
effect of the pre-introduced zootoxin Apis mellifera 
Caucasica with a single gamma irradiation of 60Co mice 
at doses of 1.3, 5, 7, 10 Gy at irradiation dose rates of 1 
Gr / min. 
Injection of venom followed by  gamma irradiation of 
60Co at a dose of D = 1, 3, 5 and 7 Gy at an irradiation 
dose rate of 1 Gy / min increased the life span of the 
experimental groups of mice ranging from 45% to 56 % 
and from 52% to 67%, respectively. 
An increase in the lifespan of experimental animals 
exposed to radiation with the preliminary introduction of 
the venom of the honey bee Apis mellifera Caucasica was 
revealed. 
Keywords— honey bee, Apis mellifera Caucasica, 
venom, radioprotective action. 
 
I. INTRODUCTION 
The problem of anti-radiation protection is becoming 
increasingly important in connection with the expansion 
of the use of ionizing radiation sources in various areas of 
human activity. 
Important tasks of modern pharmacology are the search 
and development of new effective medicines for the 
prevention and treatment of various diseases, the study of 
the mechanisms of their action in animal experiments and 
the scientific rationale for rational schemes for their 
application. One of the most severe pathologies, requiring 
intensive pharmacotherapy and prevention, are radiation 
injuries arising from acute external radiation exposure [1, 
2] 
At present, radioprotectors are the most studied and 
highly effective medical means of radiation protection 
[10, 15]. However, their use is limited to the periods of 
use (exclusively up to radiation exposure), often by a 
small therapeutic breadth and, as a consequence, enough 
high toxicity in optimal radioprotective doses. 
Preparations of cytokines and growth factors are 
considered as the most promising pharmacological agents 
for early therapy of radiation pathology [3, 4, 5, 6]. 
Prevention of adverse effects of irradiation in hazardous 
doses to humans is achieved through the use of preventive 
anti-radiation means of radioprotectors.  
However, existing radioprotectors do not always meet the 
requirements for efficacy and tolerability [7, 8]. 
In this regard, both in our country and abroad, the search 
for new radioprotectors from various classes of chemical 
compounds, as well as compounds of natural origin, 
continues. 
During the study of  the radioprotective effect of 
anticoagulants, it was found that heparin in the 
recommended radio-protective dose of 250 U / kg raises 
the survival rate of irradiated animals with respect to 
control by 40-50%.  
As the dose decreases by 1 and 2 orders of magnitude, the 
effectiveness of the drug decreases and when 
administered at a dose of 2.5 U / kg, the survival gain was 
only 10%. However, the subsequent reduction in the dose 
of heparin to 0.25 U / kg was again accompanied by an 
increase in its radioprotective effect: 
Survival increased to 40-50%, in peripheral blood not 
only the number of neutrophilic leukocytes, but also the 
content of cationic proteins in them (according to the 
lysosomal cation test) significantly increased [9]. 
No less active is the study of the radioprotective action of 
zootoxins and preparations of animal origin. In the 
research of A.S. Koryagina (2006) the radioprotective 
effect of honey bee venom was studied in detail. For this 
purpose, rats were injected intraperitoneally with a bee 
venom at a dose of 0.1 μg / kg for 7 days at a frequency of 
1 time per day.  
A single total gamma irradiation (60Co) at a dose of 3 Gy 
(dose rate of 1 Gy / min) was performed 7 days after the 
end of injections in the first series of experiments, after 14 
days in the second series, 21 days later in the third series 
and 28 Days in the fourth series of experiments. The 
radioprotective effects of the bee venom were most 
pronounced in the first 3 weeks after the end of the 
injections of zootoxin. During this period, bee venom 
significantly increased the total number of surviving bone 
marrow cells. On the 28th day after the injection of 
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venom, there was a significant decrease in its anti-
radiation activity, although it did not disappear 
completely. The author believes that the radioprotective 
effect of bee venom is associated with the formation of a 
nonspecific adaptation reaction [12]. 
Thus, analyzing the sources of modern literature, it should 
be noted that domestic and foreign scientists have studied 
the radioprotective properties of drugs from various 
pharmacological groups, but currently the search for 
radioprotectors is actively continuing. All this is due to 
the relatively low radio-protective efficacy of the 
substances studied, the toxic properties of radioprotectors 
and the inability to use them for a long time. However, it 
is necessary to note the prospects for solving this issue, 
which may be due to the combined use of radioprotective 
drugs from various pharmacological groups. 
Bee venom Apis mellifera is a complex mixture of 
enzymes and polypeptides with low molecular weight, 
including enzymes phospholipase A2, hyaluronidase, 
phosphomonoesterase, acid esterase, D-glucosidase, 
lysophospholipase, A-galactosidase, α-acetylaminodeoxy 
glucosidase and arylamidase 
It has been revealed that the effect of bee venom on the 
body shows a decrease in the protein content in the blood 
serum, which is due to the effect of poison on vascular 
permeability. 
The lethal dose of bee venom for humans is 1.4 mg per 1 
kg of body weight. The lethal outcome comes most often 
from the paralysis of the respiratory center [13, 14]. 
Because of anticoagulant and anti-inflammatory 
properties, bee venom is mainly used to treat many 
inflammatory diseases such as arthritis, bursitis, herpes 
zoster, joint disease and rheumatoid arthritis Lyme 
disease, multiple sclerosis and osteoarthritis [16, 17, 18, 
19, 20, 21, 22], 
Proceeding from a few studies on the effect of bee venom 
on the life expectancy of experimental animals exposed to 
radiation a number of issues remain unexplored and is of 
great scientific and practical interest. 
Analyzing the literature data on the degree of study of the 
venom of honey bees, the aim of the studies was to study 
the radioprotective effect of the pre-introduced zootoxin 
Apis mellifera Caucasica with a single gamma irradiation 
of 60Co mice at doses of 1.3, 5, 7, 10 Gy at irradiation 
dose rates of 1 Gr / min. 
 
II. MATERIAL AND METHODS  
The material of the study was ecologically pure whole 
poison collected from bees from apiaries, located on 
ecologically clean territory of Azerbaijan and venom 
irradiated with small doses of gamma radiation. After 
taking, venom was stored in a desiccator over a couple of 
calcium chloride. Water solutions of venom were 
prepared immediately before the experiment. The choice 
of doses that cause the development of the adaptation 
reaction of stable activation is due to the corresponding 
literary data (Koryagin, Erofeeva, 2004). For mice, these 
doses are 8-10 mg / kg of bee venom. In studies of 
A.Koryagin (2006), when studying the radioprotective 
effect of honey bee venom in experiments on rats, bee 
venom was injected at a dose of 0.1 μg / kg [11]. 
Proceeding from the above, the bee venom dissolved in 
physiological solution in a dose of 0.1 μg / kg, 0.2 μg / kg, 
0.5 μg / kg, 1.0 μg / kg and 2.0 μg / kg was injected to 
animals of control groups to study the radioprotective 
action of the bee venom. A single total γ-irradiation of 
60Co mice was carried out in doses of D = 1, 2, 3, 5, 7 Gy 
at irradiation dose rate of 1 Gy / min. The experiments 
were carried out in 5 series of experiments in vitro. 
 
III. THE RESULTS OF THE RESEARCH AND 
THEIR DISCUSSION 
We have considered the prevention of radiation damage to 
experimental animals by venom of the honey bee that 
occurs when external mice are irradiated. 
 





















Groups of experimental mice (venom dose in μkg / kg) 
control 0.01 0.02 0.04 0.05 
Life expectancy in days 
1 40 45 49 53 58 
3 35 37 42 46 49 
5 23 26 27 31 35 
7 18 21 24 27 28 
 
In order to study the radioprotective effect of the honey 
bee venom, a control group of mice was irradiated at D = 
1, 3, 5, and 7 Gy. Experimental groups of 2-3-month-old 
white mongrel mice with a total body weight of 18-22 
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grams were first intraperitoneally injected with bee 
venom at a dose of 0.01, 0.02, 0.04 and 0.05 mg / kg of 
body weight, 3 days at a frequency of once a day. Then, 
the first experimental group of mice was subjected to a 
single gamma irradiation of 60Co in a dose of D = 1 Gy at 
a dose rate of 1 Gy / min after 3 days, the second 
experimental group of mice after 3 days subjected to a 
single gamma irradiation of 60Co in a dose of D = 3 Gy at 
a radiation dose rate of 1 Gy / min.  The third 
experimental group of mice was subjected to a single γ-
irradiation of 60Co in a dose of D = 5 Gy at a dose rate of 
1 Gy / min 3 days after irradiation, and the fourth 
experimental group of mice, 3 days after irradiation, 
subjected to single 60Co γ-irradiation at a dose of D = 7 
Gy radiation at a dose rate of 1 Gy / min, the fifth 
experimental group of mice 3 days later were subjected to 
single 60Co γ-irradiation at a dose of D = 10 Gy radiation 
at a dose rate of 1 Gy / min. 
The survival of mice with intraperitoneal injection of bee 
venom at a dose of 0.01, 0.02, 0.04 and 0.05 mg / kg of 
body weight followed by a single γ-irradiation of 60Co in 
a dose of D = 1 Gy at a dose rate of 1 Gy / min is given in 
Table 1. 
The following  5, 6, 7, and 8 groups of experimental mice 
were injected intramuscularly with bee venom at a dose of 
0.1 mg / kg body weight followed by a single γ-irradiation 
of 60Co irradiation at a dose of D = 1 Gy at dose rate of 1  
Gy / min. 
The survival of mice with intramuscular injection of bee 
venom at a dose of 0.01, 0.02, 0.04, and 0.05 mg / kg of 
body weight followed by a single γ-irradiation of 60Co at 
a dose of 1, 3, 5 and 7 Gy at an irradiation dose rate of 1 
Gy / min ( table 2). 
 




















Groups of experimental mice (venom dose in μkg / kg) 
control 0.01 0.02 0.04 0.05 
Life expectancy in days 
1 40 47 51 55 61 
3 35 38 44 47 50 
5 23 27 29 33 36 
7 18 23 26 28 30 
 
The following 9, 10, 11, 12, and 13 groups of experimental mice were injected intraperitoneally with bee venom at a dose of 
0.01, 0.02, 0.04 and 0.05 mg / kg of body weight after a day, subjected to a single gamma irradiation of 60Co at a dose of D 
= 1, 3, 5 and 7 Gy at an irradiation dose rate of 1 Gy / min. 
 




















Groups of experimental mice (venom dose in μkg / kg) 
control 0.01 0.02 0.04 0.05 
Life expectancy in days 
1 40 42 45 48 52 
3 35 36 39 43 48 
5 23 25 26 29 33 
7 18 19 21 23 25 
 
The survival rate of mice with intraperitoneal injection of 
bee venom at a dose of 0.01, 0.02, 0.04 and 0.05 mg / kg 
of body weight, followed by (after one day) by a single 
gamma irradiation of 60Co at a dose of D = 1, 3, 5 and 7 
Gy at an irradiation dose rate of 1 Gy / Min is shown in 
table 3. 
The following 14, 15, 16, and 17 experimental groups 
were intramuscularly injected with bee venom at a dose of 
0.01, 0.02, 0.04 and 0.05 mg / kg of body weight after a 
day, subjected to single γ-irradiation of 60Co at a dose of 
D = 1, 3, 5 and 7 Gy at Dose rate of 1 Gy / min. 
The survival of mice with intramuscular injection of bee 
venom at a dose of 0.01, 0.02, 0.04 and 0.05 mg / kg of 
body weight with a single (after a day) γ-irradiation of 
60Co in a dose of D = 1, 3, 5 and 7 Gy at a dose rate of 1 
Gy / Min are given in Table 4. 
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Groups of experimental mice (venom dose in μkg / kg) 
control 0.01 0.02 0.04 0.05 
Life expectancy in days 
1 40 43 46 49 54 
3 35 38 40 45 49 
5 23 26 27 30 35 
7 18 20 23 25 27 
 
An increase in the total number of surviving animals was 
noted in all the groups studied, but the nature of the 
change in the lifespan of mice differs both from the 
method of administration and from the time of 
administration of the poison after gamma irradiation of 
60Co. 
  In experiments on mice with intraperitoneal or 
intramuscular fractional injection of venom followed by a 
single γ-irradiation of 60Co at a dose of A = 1, 3, 5 and 7 
Gy, an increase in the lifespan of experimental groups of 
mice was noted at an irradiation dose rate of 1 Gy / min. 
The survival rate of the experimental groups of mice, in 
relation to the control group, ranged from 45% to 56% 
and from 52% to 67%, respectively. 
Survival of the experimental groups of mice, with respect 
to the control group with a single intraperitoneal or 
intramuscular injection, increased within the range of 
30% to 39% and 35% to 50%, respectively, 24 hours after 
the injection of venom. 
We believe that the radioprotective effect of bee venom is 
associated with the formation of a nonspecific adaptation 
reaction. 
Thus, we detected a radioprotective effect of the honey 
bee venom, which manifests itself in an increase in the 
lifespan of experimental animals subjected to γ-irradiation 
of 60Co. 
For the first time it was revealed that the injection of 
venom is accompanied by a prolonged radioresistance, 
reducing the effect of ionizing radiation on the life span of 
mice under conditions of a single gamma irradiation. 
Consecutive introduction of bee venom to radiation 
exposure and in the early periods after irradiation allows 
to increase the survival time of experimental animals 
subjected to irradiation. 
Investigation of the radioprotective effect of the course 
injection of small doses of bee venom under conditions of 
a single fractionated gamma irradiation makes it possible 
to broaden the notion of nonspecific radioresistance and 
suggests the possibility of creating new preparations on 
the basis of biologically active substances of animal 
origin that enhance the radioresistance of the organism. 
The practical significance of using bee venom in small 
doses is that they can be considered as a drug of choice in 
conditions of fractionated and, possibly, chronic exposure 
to ionizing radiation. 
Radioresistance, which develops in the body in response 
to multiple injections of bee venom, can successfully 
protect the body from fractionated gamma irradiation. 
 
IV. CONCLUSIONS 
1. The increase in the lifespan of mice differs from the 
method of injection, and the time of injection of the 
venom after γ-irradiation. 
2. Intraperitoneal or intramuscular fractional injection 
of venom followed by a single gamma irradiation of 
60Co at a dose of D = 1, 3, 5 and 7 Gy at an 
irradiation dose rate of 1 Gy / min increased the life 
span of the experimental groups of mice ranging 
from 45% to 56 % And from 52% to 67%.  
3. At a single (after 24 hours) intraperitoneal or 
intramuscular injection of the venom, the life span of 
the experimental groups of mice increased from 30% 
to 39% and from 35% to 50%, respectively. 
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